Total Payments
$36,529
2024 Payments
$3,640
Companies
97
Transactions
1,871
Medicare Patients
8,680
Medicare Billing
$2.3M
Payment Breakdown by Category
Food & Beverage$36,088 (98.8%)
Education$214.89 (0.6%)
Other$179.16 (0.5%)
Gifts$47.45 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $36,088 | 1,822 | 98.8% |
| Education | $214.89 | 24 | 0.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $179.16 | 9 | 0.5% |
| Gift | $47.45 | 16 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $3,171 | 70 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $3,166 | 157 | $0 (2024) |
| ABBVIE INC. | $2,753 | 132 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,643 | 172 | $0 (2024) |
| Amgen Inc. | $2,114 | 83 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,960 | 92 | $0 (2024) |
| Novo Nordisk Inc | $1,515 | 91 | $0 (2024) |
| Esperion Therapeutics, Inc. | $1,168 | 62 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,077 | 37 | $0 (2021) |
| Lilly USA, LLC | $1,002 | 59 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,640 | 155 | ABBVIE INC. ($508.89) |
| 2023 | $4,255 | 200 | AbbVie Inc. ($529.86) |
| 2022 | $3,958 | 204 | ABBVIE INC. ($471.49) |
| 2021 | $4,908 | 271 | AbbVie Inc. ($642.04) |
| 2020 | $4,204 | 226 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($456.58) |
| 2019 | $5,183 | 277 | Amarin Pharma Inc. ($930.17) |
| 2018 | $4,934 | 255 | Amarin Pharma Inc. ($861.75) |
| 2017 | $5,449 | 283 | Amarin Pharma Inc. ($825.40) |
All Payment Transactions
1,871 individual payment records from CMS Open Payments — Page 1 of 75
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $31.96 | General |
| Category: Bone Health | ||||||
| 12/20/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Diabetes | ||||||
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $13.95 | General |
| Category: GI | ||||||
| 12/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $31.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | VIVUS LLC | PANCREAZE (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: DIABETES | ||||||
| 12/06/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Almatica Pharma LLC | TERIPARATIDE (Drug), LOREEV XR | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: OSTEOPOROSIS | ||||||
| 11/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $34.64 | General |
| Category: Bone Health | ||||||
| 11/25/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $4.16 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Gastroenterology | ||||||
| 11/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,123 | 8,221 | $888,091 | $535,304 |
| 2022 | 13 | 2,181 | 8,576 | $956,690 | $570,516 |
| 2021 | 12 | 2,110 | 9,035 | $945,165 | $583,194 |
| 2020 | 13 | 2,266 | 10,116 | $883,050 | $589,312 |
Total Patients
8,680
Total Services
35,948
Medicare Billing
$2.3M
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 882 | 6,375 | $764,906 | $476,603 | 62.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 315 | $39,375 | $21,370 | 54.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 103 | 210 | $28,350 | $9,517 | 33.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 43 | $10,750 | $6,395 | 59.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 555 | 707 | $10,605 | $5,939 | 56.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 36 | $5,400 | $4,212 | 78.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 35 | 44 | $7,700 | $3,076 | 39.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 18 | $3,150 | $1,965 | 62.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $4,305 | $1,928 | 44.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $3,250 | $1,867 | 57.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 300 | 343 | $5,145 | $1,101 | 21.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 62 | 64 | $4,160 | $803.52 | 19.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 13 | 13 | $455.00 | $274.82 | 60.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 12 | 12 | $540.00 | $253.68 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 889 | 6,270 | $752,400 | $472,856 | 62.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 61 | 742 | $92,875 | $47,428 | 51.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 70 | 96 | $24,000 | $16,834 | 70.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 114 | 259 | $34,965 | $11,580 | 33.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 69 | 91 | $15,875 | $5,859 | 36.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 45 | 48 | $7,200 | $5,794 | 80.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 35 | 35 | $5,390 | $3,129 | 58.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 19 | $3,325 | $2,079 | 62.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 480 | 575 | $8,665 | $1,702 | 19.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 78 | 79 | $5,135 | $1,019 | 19.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 261 | 302 | $4,530 | $978.70 | 21.6% |
About Dr. Zaven Arslanian, M.D
Dr. Zaven Arslanian, M.D is a General Practice healthcare provider based in Glendale, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174545651.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Zaven Arslanian, M.D has received a total of $36,529 in payments from pharmaceutical and medical device companies, with $3,640 received in 2024. These payments were reported across 1,871 transactions from 97 companies. The most common payment nature is "Food and Beverage" ($36,088).
As a Medicare-enrolled provider, Arslanian has provided services to 8,680 Medicare beneficiaries, totaling 35,948 services with total Medicare billing of $2.3M. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Location Glendale, CA
- Active Since 07/24/2006
- Last Updated 11/14/2017
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1174545651
Products in Payments
- Vascepa (Drug) $3,171
- FARXIGA (Drug) $1,708
- XIFAXAN (Drug) $1,645
- JARDIANCE (Drug) $1,442
- UBRELVY (Drug) $1,264
- Ozempic (Drug) $1,042
- NEXLETOL (Drug) $809.94
- SYMBICORT (Drug) $671.38
- NUEDEXTA (Drug) $652.62
- Trulance (Drug) $646.85
- TRELEGY ELLIPTA (Drug) $639.99
- TRULANCE (Drug) $637.56
- EVENITY (Biological) $618.79
- Prolia (Biological) $609.00
- Linzess (Drug) $581.60
- LINZESS (Drug) $572.90
- ENTRESTO (Drug) $563.25
- INVOKANA (Drug) $541.36
- TRINTELLIX (Drug) $535.93
- Otezla (Drug) $516.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Glendale
Dr. Lee Brady, D.m.d, D.M.D
General Practice — Payments: $769,767
General Practice $769,767
Dr. Matthew Parker, Dmd, DMD
General Practice — Payments: $114,875
General Practice $114,875
Dr. H Kojian, Md, MD
General Practice — Payments: $20,562
General Practice $20,562
Andre Eliasian, Dds, DDS
General Practice — Payments: $20,543
General Practice $20,543
Dr. Donald Hildebrandt, D.d.s, D.D.S
General Practice — Payments: $19,206
General Practice $19,206
Jerrick Padilla-Phu, Fnp, FNP
General Practice — Payments: $17,565
General Practice $17,565